Vimarsana
Biggest News Aggregation in the World

Immunic News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Immunic. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Immunic Today - Breaking & Trending Today

Immunic, Inc. to Announce Financial Results for the First Quarter Ended March 31, 2024, and Provide Corporate Update - Vimarsana News

Immunic, Inc. to Announce Financial Results for the First Quarter Ended March 31, 2024, and Provide Corporate Update

/PRNewswire/ -- Immunic, Inc. (Nasdaq: IMUX), a biotechnology company developing a clinical pipeline of orally administered, small molecule therapies for...

Immunic (NASDAQ:IMUX) Downgraded to Sell at StockNews.com - Vimarsana News

Immunic (NASDAQ:IMUX) Downgraded to Sell at StockNews.com

StockNews.com cut shares of Immunic (NASDAQ:IMUX – Free Report) from a hold rating to a sell rating in a research note published on Saturday morning. Separately, Brookline Capital Management reaffirmed a buy rating and set a $10.00 target price on shares of Immunic in a research report on Friday, April 5th. View Our Latest Report […]

Source: wkrb13.com
Biotech Stock News Bite - Immunic, Inc. (Nasdaq: IMUX) Year End 2023 Financial Results and Provides Corporate Update - Vimarsana News

Biotech Stock News Bite - Immunic, Inc. (Nasdaq: IMUX) Year End 2023 Financial Results and Provides Corporate Update

Biotech Stock News Bite - Immunic, Inc. (Nasdaq: IMUX) Year End 2023 Financial Results and Provides Corporate Update

Immunic (IMUX) to Release Earnings on Thursday - Vimarsana News

Immunic (IMUX) to Release Earnings on Thursday

Immunic (NASDAQ:IMUX – Get Free Report) will be announcing its earnings results before the market opens on Thursday, February 22nd. Analysts expect the company to announce earnings of ($0.51) per share for the quarter. Immunic (NASDAQ:IMUX – Get Free Report) last released its earnings results on Tuesday, November 14th. The company reported ($0.51) EPS for […]

Leerink Partnrs Comments on Immunic, Inc.'s FY2028 Earnings (NASDAQ:IMUX) - Vimarsana News

Leerink Partnrs Comments on Immunic, Inc.'s FY2028 Earnings (NASDAQ:IMUX)

Immunic, Inc. (NASDAQ:IMUX – Free Report) – Analysts at Leerink Partnrs issued their FY2028 earnings per share estimates for shares of Immunic in a research report issued to clients and investors on Monday, February 5th. Leerink Partnrs analyst T. Smith expects that the company will earn ($0.66) per share for the year. The consensus estimate […]